Review

Kan androjen düzeyleri ile BPH arasında bir ilişki var mıdır?

• Murat Çakan
• Uğur Altuğ

• Öztug Adsan
• Sümer Baltaci

• Bülent Akdogan
• Haluk Özen

Benign prostat hiperplazisi'nde ultrason takibinin rolü

• Ayhan Dirim

An update on palliative therapy in advanced prostate cancer

• Kaan Özdedeli
• Uğur Kuyumcuoğlu

TUR-M sonrası tek doz intravezikal tedavi: Kime ve hangi ilaçla?

• Hayrettin Şahin

• Ibrahim Cüreklibatir
• Serkan Demiryoguran

Genetik alteration in bladder carcinoma

• Hakan Akça
• Onur Tokgün

Radikal sistektomi sonrası nükslerin tanı ve tedavisi

• Ali Tekin

The Relationship between Bladder Cancer and Epigenetic Alterations

• Ata Özen
• Ali Ülgen
• Cavit Can

What is the current status of bladder tumor markers?

• İbrahim Dönmez
• N. Aydın Mungan

BPH ile Prostatın enflamatuar hastalıkları arasındaki ilişki ve tedavide benzerlik olabilir mi?

• Ümit Yıldırım
• Ferruh Zorlu

Radikal sistektomi öncesi ve sonrası nomogram kullanımı: Yakın gelecekteki rolü

• Kadir Türkölmez

TUR prostat sonrası gelişen hiperaktif mesane bulguları neden oluyor, nasıl tedavi etmeli?

• Ceyhun Özyurt

Radikal sistektomi öncesinde ve sonrasında beslenmenin önemi

• Güven Aslan

Cerrahi sonrası radyoterapi: Endikasyon, etkinlik ve zamanlama

• Şefik İğdem

Bipolar veya plazmakinetik enerji ile yapılan TUR-M operasyonlarının klasik metottan farkı var mı?

• Binhan Kağan Aktaş
• Mehmet Murat Baykam

Metabolic Changes Developing During Urinary Intestinal Diversion after Radical Cystectomy

• Mehmet Remzi Erdem
• Feridun Şengör

Approach to the complications of intravesical therapy in bladder cancer

• Turgay Gülecen
• Cüneyd Özkürkçügil

Re-operation rates and possible causes related to minimally invasive and surgical treatments of Benign Prostatic Hyperplasia

• Serdar Toksöz
• Hakan Özkardeş

Radikal prostatektomi teknikleri arasında üroonkolojik sonuçlar açısından fark var mı?

• Gökhan Faydacı
• Uğur Kuyumcuoğlu

TUR'a bağlı mesane perforasyonu: tedavi ve izlem

• Kürsad Zengin
• Sinan Başay

Üriner diversiyon ve sistoplasti sonrası gelişen sekonder malignansiler

• Mustafa Kaplan

Nefrektomi sonrası metastazlarda gerileme. Şehir efsanesi mi gerçek mi?

• Özcan Kılıç
• Serdar Göktaş

Tekrarlayan prostat biyopsilerinde ideal bir biyopsi şeması var mıdır? PCA3 PSA kadar faydalı mıdır?

• Kaya Horasanlı
• Mustafa Aydın

Algorithmic approach to rising PSA after curative prostate cancer treatment

• Levent Mert Günay
• Şevket Tolga Tombul
• Bülent Akdoğan

The Role of Imaging in Testicular Cancer Diagnosis, Staging and Follow-up

• Nuray Voyvoda
• Bekir Voyvoda
• Özden Çamurdan

Is TUR-B operations can be done in the office conditions by using local anesthesia

• Tansu Değirmenci
• Bülent Günlüsoy

Radiological methods that aid in the diagnosis of bladder cancer

• Fatih Kantarcı
• Deniz Çebi Olgun
• Atilla Süleyman Dikici

Are radiological imagings useful in diagnosis, treatment and follow-up of Benign Prostatic Hyperplasia?

• Umut Gönülalan
• Bülent Öztürk

Quality of Life after Radical Cystectomy and Diversion

• Gökhan Toktaş
• Emre Karabay

Sistektomi sonrası yaşam kalitesi ne zaman ölçülmelidir?

• Cem Akbal
• Mahir Bülent Özgen

Outstanding variations in the treatment of prostate cancer bone metastases

• İbrahim Cüreklibatır

Seminomlarda primer kemoterapi sonrası residüel kitlelere yaklaşım

• Mustafa Sofikerim
• Abdullah Demirtaş

Management of post-chemotherapy residual masses in testicular tumor and surgical tecnique

• Ferhat Ateş
• Ömer Yılmaz
• Kadir Vehbi Baykal

Magnetic Resonance - Transrectal Ultrasound Fusion Guided Prostate Biopsy

• Ömer Burak Argun
• Can Öbek
• Ali Rıza Kural

Approaches to Upper Urinary Tract Recurrences Following Radical Cystectomy

• Mehmet İlker Gökçe
• Sümer Baltacı

Comparison of the Clinical and Pathologic Staging in Patients Undergoing Radical Cystectomy, the Factors Associated with Upstaging and its Effect on Outcome

• Polat Türker

Are there any treatment option for metastatic prostate cancer refractory to docetaksel?

• Yaşar Bedük

New treatment options for the castration resistant prostate cancer targeting the androgen synthesis and androgen receptor

• Yavuz Selim Süral
• Çağ Çal

New treatment options in castration resistant prostate cancer: enzalutamide and abiraterone acetate

• Bülent Akdoğan

Early and Late Complications of Urinary Diversions after Radical Cystectomy

• Umut Gönülalan
• Murat Koşan

New treatment options for the castration resistant prostate cancer: Cabazitaxel and Spileucel-T

• Gürbüz Görümlü
• Erdem Göker

New treatment options in castration resistant prostate cancer: denosumab, alpharadin

• Hakan Gemalmaz

Bladder Perforation During TUR of Non Muscle Invasive Bladder Tumours: Early and Late Management

• Deniz Arslan

Treatment Approaches for Nonmetastatic Castration-Resistant Prostate Cancer

• Mehmet Yıldızhan
• Hakan Gemalmaz
• Mehmet Şirin Ertek

Current Status of Laparoscopic Radical Nephroureterectomy in the Treatment Modalities for Upper Urinary Tract Tumors

• Ahmet Güdeloğlu
• Cenk Yücel Bilen

How shoud PSA repalse (rising PSA) be managed after radical prostatectomy? How should treatment algorithms be shaped?

• İlker Çelen
• Murat Lekili

Management of recurrences after radiation therapy used for curative intent in prostate cancer

• Yılören Tanıdır
• Levent Türkeri

Salvage radical prostatectomy for locally recurrent prostate cancer following primary radiotherapy

• Ali Cansu Bozacı
• Sertaç Yazıcı

Management of infravesical strictures after radical retropubic prostatectomy

• Mustafa Karalar
• İbrahim Keleş
• Mutlu Ateş

Is there a role of intraoperative ultrasonography in decision of partial / total nephrectomy?

• Mustafa Seçil

AUA/ASTRO 2013 Guidelines for Adjuvant and Salvage Radiation Therapy After Prostatectomy: What are the Yields and the Changes?

• Deniz Yalman

‘Nanotechnology Applications’ in the Treatment of Prostate Cancer

• Ali Furkan Batur
• Kerem Gencer Kutman
• Mustafa Suat Bolat

Immunotherapy for the treatment of castration resistant prostate cancer: sipuleucel-T

• Güven Aslan

New treatment stragies in metastatic castration resistant prostate cancer: Re-Docetaxel, Abiraterone asetate, Cabazitaxel, MDV 3100

• Sıtkı Ün
• Ferruh Zorlu

Rising Psa After Radical Prostatectomy: Radiotherapy in High Risk Group: Early? Late?

• Gül Alço
• Sefik İğdem

Surgical Approach to the Patients with Positive Surgical Margin after Nephron Sparing Surgery

• Bülent Günlüsoy
• Yasin Ceylan
• Tansu Değirmenci

Postchemotherapy Retroperitoneal Lymph Node Dissection

• Burak Çıtamak
• Bülent Akdoğan
• Mesut Altan
• Haluk Özen

The Current Radiological Approach to Renal Cell Carcinoma

• Nuray Voyvoda
• Bekir Voyvoda
• Ömür Memik

F-18 fluorodeoxyglucose positron emission tomography in testicular cancer

• Gül Gümüser
• Feray Aras
• Elvan Sayit Bilgin

Follow-up principles after curative treatment in renal cancer

• Ercan Kazan
• Hakan Gemalmaz

Should the treatment approach be different for incidental renal tumors? Turkey databases

• Emre Huri

Impact of Renal Ischemia on Renal Failure After Partial Nephrectomy

• Yavuz Selim Süral
• Ahmet Çag Çal

Recommendations from the 2012 International Society of Urological Pathology Vancouver Consensus Conference on Renal Tumors

• Ayşe Ayşim Özağarı

The Efficacy of Early Mobilization after Urologic Radical Surgery

• Sevgi Vermişli
• Kamil Çam

Article - Comment

Superficial (pT2a) and deep (pT2b) muscle invasion in pathological staging of bladder cancer following radical cystectomy

• M. Gökhan Özer

• Emre Tüzel

The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma

• Duygu Düsmez Apa

The increasing use of intravesical therapies for stage T1 bladder cancer coincides with decreasing survival after cystectomy

• Hayrettin Sahin

Time to prostate spesific antigen recurrence after radical prostatectomy and risk of prostate cancer specific mortality

• Mustafa Kaplan

Radiochemotherapy after transurethral resection for high-risk T1 bladder cancer: An alternative to intravesical therapy or early cystectomy?

• Murat Bozlu

Prognostic impact of tumor size on pT2 renal cell carcinoma: An international multicenter experience

• Semih Ayan

Radical cystectomy after bacillus Calmette-Guerin for high-risk Ta, T1, and carcinoma in situ: defining the risk of initial bladder preservation

• Ugur Kuyumcuoglu
• Gökhan Faydaci

Long-term survival in men with high grade prostate cancer: a comparison between conservative treatment, radiation therapy and radical prostatectomy—a propensity scoring approach

• Cemil Uygur

Adjuvant weekly docetaxel for patients with high risk prostate cancer after radical prostatectomy: a multi-institutional pilot study

• Kadir Baykal
• Hasan Soydan

• Saadettin Yilmaz Eskiçorapçi

Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials

• Hakan Gemalmaz

Quality of life, sexual function and decisional regret at 1 year after surgical treatment for localized prostate cancer

• Recep Büyükalpelli

Saturation Technique Does Not Decrease Cancer Detection During Followup After Initial Prostate Biopsy

• Ali İhsan Arık

Is There Evidence of a Relationship between Benign Prostatic Hyperplasia and Prostate Cancer? Findings of a Literature Review

• Oğuz Acar

Surgical resection of renal cell carcinoma after targeted therapy

• Asıf Yıldırım

Prediction of Response to Androgen Deprivation Therapy and Castration Resistance in Primary Metastatic Prostate Cancer

• Ali F. Şahin

Quality Of Life

Association of the Benign Prostatic Hyperplasia and erectile dysfunction, the current treatment modalities in Benign Prostatic Hyperplasia

• Volkan Şen
• Ömer Demir
• Ahmet Adil Esen

Management of post radical retropubic prostatectomy incontinence

• Adnan Şimşir
• Gökhan Temeltaş

Can we prevent erectile dysfunction following radical prostatectomy? What are the medical and surgical alternatives?

• Cem Akbal
• Ferruh Şimsek

Radiation Oncology

Possible problems and solutions after radiation therapy for prostate cancer

• Serdar Özkök

Bph

The role of phosphodiesterase type-5 inhibitors in Benign Prostatic Hyperplasia, current approaches

• Eray Kemahlı
• Adnan Gücük
• Uğur Üyetürk

Robot assisted simple prostatectomy: is it rationale?

• Levent Mert Günay
• Mehmet Cemil Uygur